New Analysis Finds Medicare, Taxpayers Could Save $8.2B a Year if Seniors Were Prescribed Generics for Cholesterol Reduction

U.S. Newswire, January, 2006

WASHINGTON, Jan. 11 /U.S. Newswire/ -- Potential savings of $8.2 billion could be achieved in 2007 if Medicare beneficiaries were prescribed effective, lower-cost generic statins to reduce cholesterol instead of higher-priced brands, according to a new analysis by Consumers Union and Consumer Reports Best Buy Drugs. The savings would accrue to taxpayers, Medicare drugs plans, and beneficiaries themselves.

"Lower-cost cholesterol drugs are just as effective and safe, and the savings from switching to them could be dramatic," said Gail Shearer, Consumer Reports Best Buy Drugs project director. The independent, public education project uses analyses of the scientific evidence to recommend "Best Buys" in prescription drugs based on safety, effectiveness, and price. (The analysis...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here